Fig. 6From: Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trialAZD7594 Plasma concentrations at Steady-state (Day 14) Arithmetic means by dose level vs time after dose (pharmacokinetic analysis set). Error bars represent standard deviation. n: number of subjectsBack to article page